Literature DB >> 15845898

Immunomodulatory effects of HSV-2 infection on immature macaque dendritic cells modify innate and adaptive responses.

Silvia Peretti1, Andrew Shaw, James Blanchard, Rudolf Bohm, Gavin Morrow, Jeffrey D Lifson, Agegnehu Gettie, Melissa Pope.   

Abstract

Herpes simplex viruses (HSV) infect human and murine dendritic cells (DCs) and interfere with their immunostimulatory functions in culture. HSV-2 infection increases human immunodeficiency virus (HIV) spread in patients, and DCs also promote HIV infection. We have studied these topics in rhesus macaque monocyte-derived DCs (moDCs) to set the stage for future studies of these issues in animals. We provide the first evidence that macaque DCs become infected by HSV-2. Structural viral proteins (ICP5 [infected cell protein 5], glycoprotein D [gD], envelope) were detected in the cell periphery, and a functional protein (infected cell protein 8 [ICP8]) was predominantly found in the nucleus after infection. Infectious HSV-2 induced apoptotic death, decreased expression of HLA-DR, CD40, CD80, CD83, and CD86, and increased release of interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha), macrophage inflammatory protein-1alpha (MIP-1alpha) (CCL3), and RANTES (regulated on activation normal T cells expressed and secreted) (CCL5) but not IL-12 or interferon-alpha (IFN-alpha) by macaque DCs. This coincided with HSV-2-infected DCs stimulating weak T-cell responses, including impaired SIV-specific responses. Comparable HSV-2 protein expression, DC apoptosis, as well as membrane immunophenotype and functional modifications were observed in HSV-2-exposed human moDCs. Such HSV-2-induced modifications of macaque and human DCs could augment DC-driven immunodeficiency virus infection. This work affords the basis for future macaque studies to explore how HSV-2 impacts the efficacy of strategies being developed to prevent HIV transmission.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15845898      PMCID: PMC1895187          DOI: 10.1182/blood-2004-12-4899

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  46 in total

1.  Epidermal viral immunity induced by CD8alpha+ dendritic cells but not by Langerhans cells.

Authors:  Rhys S Allan; Chris M Smith; Gabrielle T Belz; Allison L van Lint; Linda M Wakim; William R Heath; Francis R Carbone
Journal:  Science       Date:  2003-09-26       Impact factor: 47.728

2.  Immunodeficiency virus uptake, turnover, and 2-phase transfer in human dendritic cells.

Authors:  Stuart G Turville; John J Santos; Ines Frank; Paul U Cameron; John Wilkinson; Monica Miranda-Saksena; Joanne Dable; Hella Stössel; Nikolaus Romani; Michael Piatak; Jeffrey D Lifson; Melissa Pope; Anthony L Cunningham
Journal:  Blood       Date:  2003-11-20       Impact factor: 22.113

3.  Inhibition of dendritic cell maturation by herpes simplex virus.

Authors:  M Salio; M Cella; M Suter; A Lanzavecchia
Journal:  Eur J Immunol       Date:  1999-10       Impact factor: 5.532

4.  Herpes simplex virus infection of human dendritic cells induces apoptosis and allows cross-presentation via uninfected dendritic cells.

Authors:  Lidija Bosnjak; Monica Miranda-Saksena; David M Koelle; Ross A Boadle; Cheryl A Jones; Anthony L Cunningham
Journal:  J Immunol       Date:  2005-02-15       Impact factor: 5.422

5.  Human immunodeficiency virus type 1 activates plasmacytoid dendritic cells and concomitantly induces the bystander maturation of myeloid dendritic cells.

Authors:  Jean-François Fonteneau; Marie Larsson; Anne-Sophie Beignon; Kelli McKenna; Ida Dasilva; Ali Amara; Yong-Jun Liu; Jeffrey D Lifson; Dan R Littman; Nina Bhardwaj
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

6.  Presentation of exogenous whole inactivated simian immunodeficiency virus by mature dendritic cells induces CD4+ and CD8+ T-cell responses.

Authors:  Ines Frank; John J Santos; Erin Mehlhop; Loreley Villamide-Herrera; Christine Santisteban; Agegnehu Gettie; Ralf Ignatius; Jeffrey D Lifson; Melissa Pope
Journal:  J Acquir Immune Defic Syndr       Date:  2003-09-01       Impact factor: 3.731

Review 7.  Immunodeficiency virus exploitation of dendritic cells in the early steps of infection.

Authors:  Natalia Teleshova; Ines Frank; Melissa Pope
Journal:  J Leukoc Biol       Date:  2003-07-22       Impact factor: 4.962

8.  HIV-1-infected monocyte-derived dendritic cells do not undergo maturation but can elicit IL-10 production and T cell regulation.

Authors:  Angela Granelli-Piperno; Angelika Golebiowska; Christine Trumpfheller; Frederick P Siegal; Ralph M Steinman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-05       Impact factor: 11.205

Review 9.  The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemics.

Authors:  Lawrence Corey; Anna Wald; Connie L Celum; Thomas C Quinn
Journal:  J Acquir Immune Defic Syndr       Date:  2004-04-15       Impact factor: 3.731

10.  Frontline: Induction of apoptosis and modulation of c-FLIPL and p53 in immature dendritic cells infected with herpes simplex virus.

Authors:  Dagmar B Müller; Martin J Raftery; Angela Kather; Thomas Giese; Günther Schönrich
Journal:  Eur J Immunol       Date:  2004-04       Impact factor: 5.532

View more
  24 in total

Review 1.  Current concepts of HIV transmission.

Authors:  Gavin Morrow; Laurence Vachot; Panagiotis Vagenas; Melissa Robbiani
Journal:  Curr HIV/AIDS Rep       Date:  2007-02       Impact factor: 5.071

2.  Current concepts of HIV transmission.

Authors:  Gavin Morrow; Laurence Vachot; Panagiotis Vagenas; Melissa Robbiani
Journal:  Curr Infect Dis Rep       Date:  2008-05       Impact factor: 3.725

Review 3.  Simian immunodeficiency virus interactions with macaque dendritic cells.

Authors:  Natalia Teleshova; Nina Derby; Elena Martinelli; Pavel Pugach; Giulia Calenda; Melissa Robbiani
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

4.  MZC Gel Inhibits SHIV-RT and HSV-2 in Macaque Vaginal Mucosa and SHIV-RT in Rectal Mucosa.

Authors:  Giulia Calenda; Guillermo Villegas; Patrick Barnable; Claudia Litterst; Keith Levendosky; Agegnehu Gettie; Michael L Cooney; James Blanchard; José A Fernández-Romero; Thomas M Zydowsky; Natalia Teleshova
Journal:  J Acquir Immune Defic Syndr       Date:  2017-03-01       Impact factor: 3.731

5.  Role for plasmacytoid dendritic cells in the immune control of recurrent human herpes simplex virus infection.

Authors:  Heather Donaghy; Lidija Bosnjak; Andrew N Harman; Valerie Marsden; Stephen K Tyring; Tze-Chiang Meng; Anthony L Cunningham
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

6.  Herpes simplex virus type 1 (HSV-1)-induced apoptosis in human dendritic cells as a result of downregulation of cellular FLICE-inhibitory protein and reduced expression of HSV-1 antiapoptotic latency-associated transcript sequences.

Authors:  Angela Kather; Martin J Raftery; Gayathri Devi-Rao; Juliane Lippmann; Thomas Giese; Rozanne M Sandri-Goldin; Günther Schönrich
Journal:  J Virol       Date:  2009-11-11       Impact factor: 5.103

7.  Herpes simplex virus 2 (HSV-2) prevents dendritic cell maturation, induces apoptosis, and triggers release of proinflammatory cytokines: potential links to HSV-HIV synergy.

Authors:  Martha Stefanidou; Irene Ramos; Veronica Mas Casullo; Janie B Trépanier; Sara Rosenbaum; Ana Fernandez-Sesma; Betsy C Herold
Journal:  J Virol       Date:  2012-11-14       Impact factor: 5.103

8.  Herpes simplex virus remodels T-cell receptor signaling, resulting in p38-dependent selective synthesis of interleukin-10.

Authors:  Derek D Sloan; Keith R Jerome
Journal:  J Virol       Date:  2007-09-05       Impact factor: 5.103

9.  LEAPS therapeutic vaccines as antigen specific suppressors of inflammation in infectious and autoimmune diseases.

Authors:  Daniel H Zimmerman; Harold Steiner; Roy Carmabula; Eyal Talor; Ken S Rosenthal
Journal:  J Vaccines Vaccin       Date:  2012-09-20

10.  A macaque model to study vaginal HSV-2/immunodeficiency virus co-infection and the impact of HSV-2 on microbicide efficacy.

Authors:  Federica Crostarosa; Meropi Aravantinou; Onome J Akpogheneta; Edith Jasny; Andrew Shaw; Jessica Kenney; Michael Piatak; Jeffrey D Lifson; Aaron Teitelbaum; Lieyu Hu; Anne Chudolij; Thomas M Zydowsky; James Blanchard; Agegnehu Gettie; Melissa Robbiani
Journal:  PLoS One       Date:  2009-11-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.